Weekly Cisplatin plus Capecitabine is an active regimen in heavily pretreated advanced breast cancer patients

被引：0
|
作者：
Donadio, Michela [1 ]
Beano, Alessandra [1 ]
Ardine, Mara [1 ]
Bonardi, Simone [2 ]
Mistrangelo, Marinella [1 ]
Polimeni, Maria A. [1 ]
Castiglione, Federico [3 ]
Forti, Laura [4 ]
Bottini, Alberto [2 ]
Bertetto, Oscar [1 ]
机构：
[1] Azienda Osped San Giovanni Battista, COES, Turin, Italy
[2] Azienda Osped Ist Ospetalieri, Cremona, Italy
[3] Osped San Lazzaro, Alba, Italy
[4] Osped Maggiore La Carita, SCDU Oncol Med, Novara, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：46 / 46
页数：1
相关论文
共 50 条
  • [21] Metronomic capecitabine in heavily pretreated metastatic triple negative breast cancer
    El-Sadda, W. M.
    CANCER RESEARCH, 2017, 77
  • [22] Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients
    Alfredo Torres
    Jeremy L. Ramdial
    Luis E. Aguirre
    Reshma Mahtani
    Charles L. Vogel
    Breast Cancer Research and Treatment, 2019, 176 : 253 - 260
  • [23] Vinorelbine plus Capecitabine (Vinocap): a retrospective analysis in heavily pretreated HER2 negative metastatic breast cancer patients
    Torres, Alfredo
    Ramdial, Jeremy L.
    Aguirre, Luis E.
    Mahtani, Reshma
    Vogel, Charles L.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) : 253 - 260
  • [24] Salvage treatment with single-agent capecitabine in patients with heavily pretreated advanced colorectal cancer
    Ardavanis, AS
    Ioannidis, GN
    Orphanos, GS
    Rigatos, GA
    ANTICANCER RESEARCH, 2006, 26 (2B) : 1669 - 1672
  • [25] CAPECITABINE PLUS VINORELBINE COMBINATION IN PATIENTS WITH ADVANCED BREAST CANCER
    Giampaglia, M.
    Spada, M.
    Latorre, A.
    Calabrese, R.
    Sambiasi, D.
    Misino, A.
    Rinaldi, A.
    Mancarella, S.
    Vitale, S.
    Lorusso, V.
    ANNALS OF ONCOLOGY, 2004, 15 : 21 - 21
  • [26] CMFVP in heavily pretreated advanced breast cancer (BC)
    Mucciarini, Claudia
    Di Carlo, Giampaolo
    Artioli, Fabrizio
    ANNALS OF ONCOLOGY, 2007, 18 : 49 - 50
  • [27] Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL
    Di Costanzo, F
    Gasperoni, S
    Papaldo, P
    Bilancia, D
    Manzione, L
    Landucci, E
    Mazzoni, F
    Cognetti, F
    ANNALS OF ONCOLOGY, 2006, 17 (01) : 79 - 84
  • [28] Intermittent capecitabine monotherapy with lower dose intensity in heavily pretreated patients with metastatic breast cancer
    Osako, Tomo
    Ito, Yoshinori
    Takahashi, Shunji
    Tokudome, Nahomi
    Iwase, Takuji
    Hatake, Kiyohiko
    TUMORI, 2007, 93 (02) : 129 - 132
  • [29] CAPECITABINE PLUS CISPLATIN IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Wahab, Abdel M.
    Arab, Ezzel L.
    Arab, Ezzel M.
    ANNALS OF ONCOLOGY, 2010, 21 : 29 - 29
  • [30] The effect of single weekly paclitaxel in heavily pretreated patients with recurrent or persistent advanced ovarian cancer
    Kita, T
    Kikuchi, Y
    Takano, M
    Suzuki, M
    Oowada, M
    Konno, R
    Yamamoto, K
    Inoue, H
    Seto, H
    Yamamoto, T
    Shimizu, K
    GYNECOLOGIC ONCOLOGY, 2004, 92 (03) : 813 - 818
12345